Analysis finds gaps in care in treating opioid use disorders during pandemic shutdowns

(Harvard Medical School) Study finds no decrease in prescription fills or clinician visits in the first three months of the COVID-19 pandemic for patients recently receiving opioid use disorder therapy. On the flip side, the study found that during this period fewer people started new treatment for opioid use disorder and fewer urine tests were given across both new and established patients.Findings identify strengths and weaknesses in telemedicine's role for opioid use disorder during shutdowns...